NSN 6505-01-650-2681 of Lorazepam Injection - Product Details
Just NSN Parts, owned and operated by ASAP Semiconductor, is an industry-leading distributor of NSN 6505-01-650-2681 parts applicable in the aviation and defense industries. We aim to simplify the NSN 6505-01-650-2681 parts procurement process by enabling our customers to search through our inventory quickly and efficiently. Type in your desired NSN 6505-01-650-2681 part number such as NDC17478-0040-01 into our search engine and, in a matter of seconds, available stock will appear.
We pride ourselves on our attention to detail and focus on quality control. We are FAA AC 0056B accredited and AS9120B, ISO 9001:2015 certified. We offer our customers a personalized and reliable service that will change your parts procurement process. If you would like to receive a quote today, fill out a request for quote form today.
| Alternative NSN: 6505-01-650-2681 |
| Item Name:Lorazepam Injection |
| NIIN: 016502681 |
| NCB Code: USA (01) |
| Manufacturers: Akorn Inc |
Manufacturer's List for NSN 6505-01-650-2681, 6505016502681
Part Number Related To NSN 6505-01-650-2681, 6505016502681
| Part No | NSN | Item Name | QTY | RFQ |
|---|---|---|---|---|
| NDC17478-0040-01 | 6505-01-650-2681 | lorazepam injection | Avl | RFQ |
Characteristics Data of NSN 6505016502681
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE |
| FEAT | SPECIAL FEATURES | LORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG |
Get More Relevant NSN for NSN 6505-01-650-2681, 6505016502681
